A Prospective Multi-Center Randomized Controlled Single Blind Clinical Trial Evaluating the Safety and Efficacy of the Cordella Pulmonary Artery Sensor System in New York Heart Association (NYHA) Class III Heart Failure Patients (PROACTIVE-HF Trial)
Brief description of study
The main purpose of this research study is to reduce Heart Failure Hospitalizations. Endotronix, Inc. has begun a study of an investigational device (also known as the “study device”) called Cordella™ Pulmonary Artery Sensor System as a possible treatment for New York Heart Association (NYHA) Class III heart failure. An investigational device is one that has not been approved by the United States (US) Food and Drug Administration (FDA).
Clinical Study Identifier: s20-01174
ClinicalTrials.gov Identifier: NCT04089059
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
